QMS Medical Allied Services Limited (NSE:QMSMEDI)
103.00
0.00 (0.00%)
At close: Oct 6, 2025
NSE:QMSMEDI Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Cash & Equivalents | - | 10.65 | 3.05 | 23.66 | 21.63 | 13.82 | Upgrade |
Short-Term Investments | - | 32.32 | 21.06 | - | - | - | Upgrade |
Cash & Short-Term Investments | - | 42.97 | 24.11 | 23.66 | 21.63 | 13.82 | Upgrade |
Cash Growth | - | 78.24% | 1.89% | 9.38% | 56.56% | 110.86% | Upgrade |
Accounts Receivable | - | 579.31 | 436.82 | 390.44 | 420.45 | 229.82 | Upgrade |
Other Receivables | - | 12.11 | 4.8 | 10.96 | 0.44 | - | Upgrade |
Receivables | - | 603.36 | 450.96 | 407.04 | 422.12 | 231.22 | Upgrade |
Inventory | - | 393.27 | 375.83 | 299.3 | 242.55 | 203.08 | Upgrade |
Prepaid Expenses | - | 7.85 | 6.59 | 5.29 | 2.14 | 4.34 | Upgrade |
Other Current Assets | - | 152.87 | 200.24 | 134.03 | 52.38 | 45.44 | Upgrade |
Total Current Assets | - | 1,200 | 1,058 | 869.32 | 740.82 | 497.9 | Upgrade |
Property, Plant & Equipment | - | 230.11 | 232.83 | 250.5 | 79.49 | 100.22 | Upgrade |
Goodwill | - | 288.53 | - | - | - | - | Upgrade |
Other Intangible Assets | - | 37.41 | 23.5 | 14.66 | 0.24 | 1.53 | Upgrade |
Other Long-Term Assets | - | 141.57 | 39.14 | 42.89 | 4.31 | 4.09 | Upgrade |
Total Assets | - | 1,898 | 1,353 | 1,177 | 824.86 | 603.74 | Upgrade |
Accounts Payable | - | 168.95 | 197.89 | 182.86 | 160.39 | 181.91 | Upgrade |
Accrued Expenses | - | 35.12 | 9.45 | 18.84 | 25.83 | 9.39 | Upgrade |
Short-Term Debt | - | 453.83 | 310.9 | 235.43 | 295.46 | 184.03 | Upgrade |
Current Portion of Long-Term Debt | - | 54.62 | 10.83 | 5.22 | 4.55 | 1.5 | Upgrade |
Current Income Taxes Payable | - | 17.72 | 10.6 | 11.49 | 5.96 | 12.31 | Upgrade |
Other Current Liabilities | - | 1.1 | 0.01 | 0.11 | 0.03 | 0.32 | Upgrade |
Total Current Liabilities | - | 731.35 | 539.67 | 453.95 | 492.2 | 389.46 | Upgrade |
Long-Term Debt | - | 94.4 | 23.74 | 14.57 | 19.77 | 10.51 | Upgrade |
Long-Term Deferred Tax Liabilities | - | -1.59 | 3.17 | 3.94 | 2.55 | 0.54 | Upgrade |
Other Long-Term Liabilities | - | -0 | 0 | -0 | -0 | - | Upgrade |
Total Liabilities | - | 826.92 | 568.07 | 473.34 | 514.52 | 400.51 | Upgrade |
Common Stock | - | 178.5 | 178.5 | 178.5 | 37.63 | 37.63 | Upgrade |
Additional Paid-In Capital | - | 301.92 | 301.92 | 301.92 | - | - | Upgrade |
Retained Earnings | - | 416.72 | 304.72 | 223.62 | 272.72 | 165.61 | Upgrade |
Total Common Equity | - | 897.14 | 785.14 | 704.04 | 310.34 | 203.23 | Upgrade |
Minority Interest | - | 173.89 | - | - | - | - | Upgrade |
Shareholders' Equity | - | 1,071 | 785.14 | 704.04 | 310.34 | 203.23 | Upgrade |
Total Liabilities & Equity | - | 1,898 | 1,353 | 1,177 | 824.86 | 603.74 | Upgrade |
Total Debt | - | 602.86 | 345.47 | 255.22 | 319.77 | 196.03 | Upgrade |
Net Cash (Debt) | - | -559.88 | -321.36 | -231.56 | -298.13 | -182.22 | Upgrade |
Net Cash Per Share | - | -31.37 | -18.00 | -14.15 | -19.81 | -16.14 | Upgrade |
Filing Date Shares Outstanding | 17.86 | 17.85 | 17.85 | 17.85 | 17.85 | 7.53 | Upgrade |
Total Common Shares Outstanding | 17.86 | 17.85 | 17.85 | 17.85 | 15.05 | 7.53 | Upgrade |
Working Capital | - | 468.98 | 518.06 | 415.37 | 248.62 | 108.44 | Upgrade |
Book Value Per Share | - | 50.26 | 43.99 | 39.44 | 20.62 | 27.01 | Upgrade |
Tangible Book Value | - | 571.2 | 761.64 | 689.38 | 310.1 | 201.71 | Upgrade |
Tangible Book Value Per Share | - | 32.00 | 42.67 | 38.62 | 20.60 | 26.80 | Upgrade |
Buildings | - | - | 146.51 | 146.4 | 72.2 | 72.2 | Upgrade |
Machinery | - | - | 140.66 | 126.35 | 18.91 | 32.19 | Upgrade |
Leasehold Improvements | - | - | 5.58 | 5.58 | 5.58 | 5.2 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.